151 related articles for article (PubMed ID: 35780804)
1. Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance.
Hamblin R; Vardon A; Akpalu J; Tampourlou M; Spiliotis I; Sbardella E; Lynch J; Shankaran V; Mavilakandy A; Gagliardi I; Meade S; Hobbs C; Cameron A; Levy MJ; Ayuk J; Grossman A; Ambrosio MR; Zatelli MC; Reddy N; Bradley K; Murray RD; Pal A; Karavitaki N
Lancet Diabetes Endocrinol; 2022 Aug; 10(8):581-588. PubMed ID: 35780804
[TBL] [Abstract][Full Text] [Related]
2. Baseline characteristics and response to GH replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from the Pfizer International Metabolic Database.
Maiter D; Abs R; Johannsson G; Scanlon M; Jönsson PJ; Wilton P; Koltowska-Häggström M
Eur J Endocrinol; 2006 Aug; 155(2):253-60. PubMed ID: 16868138
[TBL] [Abstract][Full Text] [Related]
3. Utility of Interval Imaging During Focused Radiation Therapy for Residual Cystic Craniopharyngiomas.
Moorthy RK; Backianathan S; Rebekah G; Rajshekhar V
World Neurosurg; 2020 Sep; 141():e615-e624. PubMed ID: 32522649
[TBL] [Abstract][Full Text] [Related]
4. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.
Brada M; Ford D; Ashley S; Bliss JM; Crowley S; Mason M; Rajan B; Traish D
BMJ; 1992 May; 304(6838):1343-6. PubMed ID: 1611331
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy, Especially at Young Age, Increases the Risk for De Novo Brain Tumors in Patients Treated for Pituitary/Sellar Lesions.
Burman P; van Beek AP; Biller BM; Camacho-Hübner C; Mattsson AF
J Clin Endocrinol Metab; 2017 Mar; 102(3):1051-1058. PubMed ID: 28359095
[TBL] [Abstract][Full Text] [Related]
6. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
[TBL] [Abstract][Full Text] [Related]
7. Risk of radiation-associated intracranial malignancy after stereotactic radiosurgery: a retrospective, multicentre, cohort study.
Wolf A; Naylor K; Tam M; Habibi A; Novotny J; Liščák R; Martinez-Moreno N; Martinez-Alvarez R; Sisterson N; Golfinos JG; Silverman J; Kano H; Sheehan J; Lunsford LD; Kondziolka D
Lancet Oncol; 2019 Jan; 20(1):159-164. PubMed ID: 30473468
[TBL] [Abstract][Full Text] [Related]
8. On the benefits and risks of proton therapy in pediatric craniopharyngioma.
Beltran C; Roca M; Merchant TE
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e281-7. PubMed ID: 21570209
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience.
Jalali R; Brada M; Perks JR; Warrington AP; Traish D; Burchell L; McNair H; Thomas DG; Robinson S; Johnston DG
Clin Endocrinol (Oxf); 2000 Jun; 52(6):695-702. PubMed ID: 10848873
[TBL] [Abstract][Full Text] [Related]
10. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years.
Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
J Clin Endocrinol Metab; 2005 Feb; 90(2):800-4. PubMed ID: 15562021
[TBL] [Abstract][Full Text] [Related]
11. [Value of postoperative radiotherapy in various tumors of the pituitary gland].
Vlahovitch B; Reynaud C; Rhiati J; Mansour H; Hammoud F
Presse Med; 1988 Apr; 17(14):675-8. PubMed ID: 2966950
[TBL] [Abstract][Full Text] [Related]
12. Radiation therapy in the multimodal treatment approach of pituitary adenoma.
Becker G; Kocher M; Kortmann RD; Paulsen F; Jeremic B; Müller RP; Bamberg M
Strahlenther Onkol; 2002 Apr; 178(4):173-86. PubMed ID: 12040754
[TBL] [Abstract][Full Text] [Related]
13. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas.
Harris JR; Levene MB
Radiology; 1976 Jul; 120(1):167-71. PubMed ID: 935443
[TBL] [Abstract][Full Text] [Related]
14. Pituitary Adenoma and Papillary Craniopharyngioma: A Rare Case of Collision Tumor and Review of the Literature.
Bteich F; El Khoury L; Nohra G; Trak V; Yazbek S; Akiki M
World Neurosurg; 2020 Jul; 139():63-69. PubMed ID: 32298831
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: a treatment planning study.
Bolsi A; Fogliata A; Cozzi L
Radiother Oncol; 2003 Jul; 68(1):1-14. PubMed ID: 12885446
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy of benign intracranial tumours.
Dissaux G; Josset S; Thillays F; Lucia F; Bourbonne V; Pradier O; Pasquier D; Biau J
Cancer Radiother; 2022; 26(1-2):137-146. PubMed ID: 34953692
[TBL] [Abstract][Full Text] [Related]
17. Intracranial tumours after external fractionated radiotherapy for pituitary adenomas in northern Sweden.
Norberg L; Johansson R; Rasmuson T
Acta Oncol; 2010 Nov; 49(8):1276-82. PubMed ID: 20429723
[TBL] [Abstract][Full Text] [Related]
18. Volumetric modulated Dynamic WaveArc therapy reduces the dose to the hippocampus in patients with pituitary adenomas and craniopharyngiomas.
Uto M; Mizowaki T; Ogura K; Miyabe Y; Nakamura M; Mukumoto N; Hirashima H; Hiraoka M
Pract Radiat Oncol; 2017; 7(6):382-387. PubMed ID: 28666908
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenomas and craniopharyngiomas: analysis of 99 cases treated with radiation therapy.
Urdaneta N; Chessin H; Fischer JJ
Int J Radiat Oncol Biol Phys; 1976; 1(9-10):895-902. PubMed ID: 185179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
